PRACTICE DATABASES AND THEIR USES IN CLINICAL RESEARCH

被引:54
作者
TIERNEY, WM
MCDONALD, CJ
机构
[1] Department of Medicine, Indiana University School of Medicine, Richard L. Roudebush Veterans Administration Hospital, Computer Science Research Section, Regenstrief Institute for Health Care, Indianapolis, Indiana
关键词
D O I
10.1002/sim.4780100406
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
A few large clinical information databases have been established within larger medical information systems. Although they are smaller than claims databases, these clinical databases offer several advantages: accurate and timely data, rich clinical detail, and continuous parameters (for example, vital signs and laboratory results). However, the nature of the data vary considerably, which affects the kinds of secondary analyses that can be performed. These databases have been used to investigate clinical epidemiology, risk assessment, post-marketing surveillance of drugs, practice variation, resource use, quality assurance, and decision analysis. In addition, practice databases can be used to identify subjects for prospective studies. Further methodologic developments are necessary to deal with the prevalent problems of missing data and various forms of bias if such databases are to grow and contribute valuable clinical information.
引用
收藏
页码:541 / 557
页数:17
相关论文
共 87 条
[21]  
Bounous E.P., Mark D.B., Pollock B.G., Hlatky M.A., Harrell F.E., Lee K.L., Rankin J.S., Wechsler A.S., Pryor D.B., Califf R.M., Surgical survival benefits for coronary disease patients with left ventricular dysfunction, Circulation, 78, pp. 1151-1157, (1988)
[22]  
Olsen D.M., Kane R.L., Proctor P.H., A controlled trial of multiphasic screening, New England Journal of Medicine, 294, pp. 925-930, (1976)
[23]  
Fineberg H.V., Clinical chemistries: The high cost of low‐cost diagnostic tests, Medical Technology: The Culprit Behind Health Care Costs?, (1979)
[24]  
Maloney T.W., Rogers D.E., Medical technology‐a different view of the contentious debate over costs, New England Journal of Medicine, 301, pp. 1413-1419, (1979)
[25]  
Williamson J.W., Alexander M., Miller G.E., Continuing education and patient care research: Physician response to screening test results, Journal of the American Medical Association, 201, pp. 118-122, (1967)
[26]  
Shapiro M.F., Hatch R.L., Greenfield S., Cost containment and labor‐intensive tests: The case of the leukocyte differential count, Journal of the American Medical Association, 252, pp. 231-234, (1984)
[27]  
Hubbell F.A., Greenfield S., Tyler J.L., Chetty K., Wyle F.A., The impact of routine admission chest X‐ray films on patient care, New England Journal of Medicine, 312, pp. 209-212, (1985)
[28]  
Califf R.M., Mark D.B., Harrell F.E., Hlatky M.A., Lee K.L., Rosati R.A., Pryor D.B., Importance of clinical measures of ischemia in the prognosis of patients with documented coronary artery disease, Journal of the American College of Cardiology, 11, pp. 20-26, (1988)
[29]  
Lee K.L., Pryor D.B., Harrell F.E., Califf R.M., Behar V.S., Floyd W.L., Morris J.J., Waugh R.A., Whalen R.E., Rosati R.A., Predicting outcome in coronary disease: Statistical models versus expert clinicians, American Journal of Medicine, 80, pp. 553-650, (1986)
[30]  
Kong D.F., Lee K.L., Harrell F.E., Boswick J.M., Mark D.B., Hlatky M.A., Califf R.M., Pryor D.B., Clinical experience and predicting survival in coronary disease, Archives of Internal Medicine, 149, pp. 1177-1181, (1989)